{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:33:37Z","timestamp":1786484017806,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4\/3-1\/2014\/NCD-II"],"award-info":[{"award-number":["5\/4\/3-1\/2014\/NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jceh.2026.103585","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:34:50Z","timestamp":1780760090000},"page":"103585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Candesartan Cilexetil Restores Renal Endothelial Function Through Modulation of the ADMA\u2013DDAH\u2013eNOS Pathway in Experimental ACLF-Associated Renal Dysfunction"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1708-4864","authenticated-orcid":false,"given":"Balasubramaniyan","family":"Vairappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"T.S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundhar","family":"Mohandas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103585_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gines","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jceh.2026.103585_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal syndrome in cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103585_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CRD.0000000000000697","article-title":"A review of terlipressin in hepatorenal syndrome: targeting endothelial dysfunction and subsequent cardiovascular adverse events","volume":"34","author":"Bielawski","year":"2024","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jceh.2026.103585_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","article-title":"Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress","volume":"7","author":"Vairappan","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.21905","article-title":"The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: the missing piece?","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103585_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18094-3","article-title":"Post-transcriptional regulation of hepatic DDAH1 with TNF blockade leads to improved eNOS function and reduced portal pressure in cirrhotic rats","volume":"7","author":"Balasubramanian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103585_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ajpath.2016.11.017","article-title":"Caveolin 1 and G-Protein-Coupled receptor Kinase-2 coregulate endothelial nitric oxide synthase activity in sinusoidal endothelial cells","volume":"187","author":"Liu","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2026.103585_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.dld.2024.08.050","article-title":"NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension","volume":"57","author":"Vairappan","year":"2025","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103585_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","article-title":"Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis","volume":"45","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103585_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ki.2009.382","article-title":"Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients","volume":"77","author":"Abedini","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2026.103585_bib12","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.3390\/ijms130911288","article-title":"Asymmetric dimethylarginine, endothelial dysfunction and renal disease","volume":"13","author":"Aldamiz-Echevarria","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103585_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hep.20579","article-title":"The human liver clears both asymmetric and symmetric dimethylarginine","volume":"41","author":"Siroen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103585_bib14","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.3748\/wjg.14.7214","article-title":"Transjugular intrahepatic portosystemic shunt-placement increases arginine\/asymmetric dimethylarginine ratio in cirrhotic patients","volume":"14","author":"Siroen","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103585_bib15","article-title":"DDAH-ADMA in the regulation of hepatic eNOS activity in acute and chronic liver failure","volume":"48","author":"Balasubramaniyan","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103585_bib16","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jceh.2026.103585_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000731","article-title":"Glutathionylation mediates angiotensin II-induced eNOS uncoupling, amplifying NADPH oxidase-dependent endothelial dysfunction","volume":"3","author":"Galougahi","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jceh.2026.103585_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/VHRM.S4650","article-title":"Candesartan cilexetil in the treatment of chronic heart failure","volume":"5","author":"Baguet","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jceh.2026.103585_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2008.380","article-title":"Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade","volume":"74","author":"Chen","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2026.103585_bib20","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/HJH.0b013e3283314bc7","article-title":"Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes","volume":"27","author":"Larrayoz","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.jceh.2026.103585_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176010","article-title":"Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF","volume":"958","author":"Vairappan","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jceh.2026.103585_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2007.01.017","article-title":"AT1 receptor antagonist candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers","volume":"46","author":"Debernardi-Venon","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1743290","article-title":"Renal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with liver cirrhosis: a nationwide cohort study","volume":"2019","author":"Hsu","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jceh.2026.103585_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.149126","article-title":"Nimbolide attenuates hepatocellular carcinoma by regulating miRNAs 21, 145 and 221 and their target gene expression","volume":"937","author":"Vairappan","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.jceh.2026.103585_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/153537020623100108","article-title":"Accumulation of symmetric dimethylarginine in hepatorenal syndrome","volume":"231","author":"Lluch","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jceh.2026.103585_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New developments in hepatorenal syndrome","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib27","doi-asserted-by":"crossref","first-page":"G145","DOI":"10.1152\/ajpgi.00097.2011","article-title":"Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats","volume":"302","author":"Balasubramaniyan","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2026.103585_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cgh.2015.06.021","article-title":"Estimation of glomerular filtration rate in patients with cirrhosis by using new and conventional filtration markers and dimethylarginines","volume":"14","author":"Mindikoglu","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115807","article-title":"The renin-angiotensin system in liver disease","volume":"25","author":"McGrath","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103585_bib30","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","author":"Angeli","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib31","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jhep.2025.07.027","article-title":"From protocol to precision: the evolving diagnosis of hepatorenal syndrome","volume":"84","author":"Nadim","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: acute disease quality initiative (ADQI) and international club of ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103585_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/lt.23655","article-title":"Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure","volume":"19","author":"Shah","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2026.103585_bib35","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases","volume":"23","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jceh.2026.103585_bib36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/00365521.2025.2563587","article-title":"Unveiling NOSTRIN as a potential diagnostic marker of vascular impairment in MASLD","volume":"60","author":"Vairappan","year":"2025","journal-title":"Scand J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:13:20Z","timestamp":1786482800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0973688326001179"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103585","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan Cilexetil Restores Renal Endothelial Function Through Modulation of the ADMA\u2013DDAH\u2013eNOS Pathway in Experimental ACLF-Associated Renal Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103585"}}